Medtronic (MDT) reported fiscal Q3 non-GAAP earnings Tuesday of $1.39 per diluted share, up from $1.30 a year earlier.
Analysts polled by FactSet expected $1.36.
Revenue for the fiscal quarter ended Jan. 24 was $8.29 billion, up from $8.09 billion a year earlier. Analysts surveyed by FactSet expected $8.33 billion.
For fiscal 2025, the medical devices and technology company maintained its previous non-GAAP EPS guidance of $5.44 to $5.50. Analysts polled by FactSet expect $5.45.
Medtronic also maintained its previous fiscal 2025 revenue growth forecast of 4.75% to 5%. Analysts surveyed by FactSet expect sales of $33.57 billion.
Shares were down nearly 1% in premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.